UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000020388 |
|---|---|
| Receipt number | R000023542 |
| Scientific Title | Underlying disease of uveitis in Japan: Systematic review and meta-analysis. |
| Date of disclosure of the study information | 2015/12/28 |
| Last modified on | 2021/12/07 17:37:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Underlying disease of uveitis in Japan:
Systematic review and meta-analysis.
Acronym
Underlying disease of uveitis in Japan:
Systematic review and meta-analysis.
Scientific Title
Underlying disease of uveitis in Japan:
Systematic review and meta-analysis.
Scientific Title:Acronym
Underlying disease of uveitis in Japan:
Systematic review and meta-analysis.
Region
| Japan |
Condition
Condition
Uveitis
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To survey Underlying disease of uveitis in Japan
Basic objectives2
Others
Basic objectives -Others
Epidemiology
Trial characteristics_1
Others
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Rate of each underlying disease to whole uveitis patients.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 0 | years-old | <= |
Age-upper limit
| 150 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Patients with uveitis
Key exclusion criteria
None
Target sample size
10000
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Nobuyuki Horita |
Organization
Yokohama City University
Division name
Graduate School of Medicine
Zip code
Address
3-9, Fukuura, Kanazawaku, Yokohama
TEL
045-787-2800
horitano@yokohama-cu.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Nobuyuki Horita |
Organization
Yokohama City University
Division name
Graduate School of Medicine
Zip code
Address
3-9, Fukuura, Kanazawaku, Yokohama
TEL
045-787-2800
Homepage URL
horitano@yokohama-cu.ac.jp
Sponsor or person
Institute
Yokohama City University, Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 12 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2015 | Year | 12 | Month | 28 | Day |
Date of IRB
| 2021 | Year | 12 | Month | 07 | Day |
Anticipated trial start date
| 2021 | Year | 12 | Month | 07 | Day |
Last follow-up date
| 2021 | Year | 12 | Month | 07 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We will include any observational study providing rate of each underlying disease to whole uveitis patients. We will also make a category "No clear underlying disease." We will focus epidemiology in Japan. Non-English written report and non-full article will be allowed. Report should include data of Japanese patients.
First, we will extract number of whole uveitis patients in a study and numbers of each underlying disease. Then, rate of each underlying disease will be meta-analyzed.
Management information
Registered date
| 2015 | Year | 12 | Month | 28 | Day |
Last modified on
| 2021 | Year | 12 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023542
